156 related articles for article (PubMed ID: 20383943)
1. Bortezomib induces apoptosis in human neuroblastoma CHP126 cells.
Luo P; Lin M; Lin M; Zhu D; Wang Z; Shen J; Yang B; He Q
Pharmazie; 2010 Mar; 65(3):213-8. PubMed ID: 20383943
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptotic cell death by mycelium extracts of Phellinus linteus in human neuroblastoma cells.
Choi YH; Huh MK; Ryu CH; Choi BT; Jeong YK
Int J Mol Med; 2004 Aug; 14(2):227-32. PubMed ID: 15254770
[TBL] [Abstract][Full Text] [Related]
4. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of bortezomib-induced apoptosis by TGF-beta in cultured human Tenon's fibroblasts: contribution of the PI3K/Akt signaling pathway.
Chung EJ; Moon SW; Jung SA; Cho YJ; Kim SW; Lee JH
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6232-7. PubMed ID: 20702821
[TBL] [Abstract][Full Text] [Related]
6. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS
Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells.
Pédeboscq S; L'Azou B; Passagne I; De Giorgi F; Ichas F; Pometan JP; Cambar J
J Exp Ther Oncol; 2008; 7(2):99-111. PubMed ID: 18771084
[TBL] [Abstract][Full Text] [Related]
9. Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.
Brignole C; Marimpietri D; Pastorino F; Nico B; Di Paolo D; Cioni M; Piccardi F; Cilli M; Pezzolo A; Corrias MV; Pistoia V; Ribatti D; Pagnan G; Ponzoni M
J Natl Cancer Inst; 2006 Aug; 98(16):1142-57. PubMed ID: 16912267
[TBL] [Abstract][Full Text] [Related]
10. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
[TBL] [Abstract][Full Text] [Related]
11. [Apoptosis in Jurkat cells induced by bortezomib combined with adriamycin].
Chen JF; Jin J
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):890-3. PubMed ID: 20193325
[TBL] [Abstract][Full Text] [Related]
12. HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib.
Furfaro AL; Piras S; Passalacqua M; Domenicotti C; Parodi A; Fenoglio D; Pronzato MA; Marinari UM; Moretta L; Traverso N; Nitti M
Biochim Biophys Acta; 2014 Apr; 1842(4):613-22. PubMed ID: 24380881
[TBL] [Abstract][Full Text] [Related]
13. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
14. Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells.
Zhen YZ; Lin YJ; Liu XJ; Shang BY; Zhen YS
Anticancer Drugs; 2013 Jul; 24(6):609-16. PubMed ID: 23698252
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells.
Tsapakidis K; Vlachostergios PJ; Voutsadakis IA; Befani CD; Patrikidou A; Hatzidaki E; Daliani DD; Moutzouris G; Liakos P; Papandreou CN
Int J Urol; 2012 Jun; 19(6):565-74. PubMed ID: 22324515
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib as a therapeutic candidate for neuroblastoma.
Armstrong MB; Schumacher KR; Mody R; Yanik GA; Opipari AW; Castle VP
J Exp Ther Oncol; 2008; 7(2):135-45. PubMed ID: 18771087
[TBL] [Abstract][Full Text] [Related]
17. [Effects of secoisolariciresinol diglucoside combined with bortezomib on induction of apoptosis in lung cancer cell line A549].
Li XW; Yang JR
Zhong Yao Cai; 2012 Feb; 35(2):248-53. PubMed ID: 22822672
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B.
Ko BS; Chang TC; Chen CH; Liu CC; Kuo CC; Hsu C; Shen YC; Shen TL; Golubovskaya VM; Chang CC; Shyue SK; Liou JY
Life Sci; 2010 Jan; 86(5-6):199-206. PubMed ID: 20006625
[TBL] [Abstract][Full Text] [Related]
19. The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway.
Luo P; Lin M; Li L; Yang B; He Q
PLoS One; 2011; 6(11):e27298. PubMed ID: 22087283
[TBL] [Abstract][Full Text] [Related]
20. A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.
Podar K; Gouill SL; Zhang J; Opferman JT; Zorn E; Tai YT; Hideshima T; Amiot M; Chauhan D; Harousseau JL; Anderson KC
Oncogene; 2008 Jan; 27(6):721-31. PubMed ID: 17653083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]